Yusuke Onozawa

INTRODUCTION: In recent years, matched therapy based on comprehensive genomic profiling (CGP) has extended the prognosis of pancreatic cancer patients. Foundation One CDx® (F1CDx) is a representative test of commercially available CGP (CACGP)…